Integra LifeSciences Holdings Corporation revised revenue guidance for the fourth quarter of 2018. For the quarter, the company expects reported revenue to be at the higher end of its previous guidance range of $378 million to $383 million. Organic revenue growth in the fourth quarter 2018 is expected to be slightly above 4%.